Anthropic says Claude AI helped discover novel enzyme system

Anthropic announced on Wednesday that its Claude AI played a role in discovering a unique enzyme system with traits similar to those found in CRISPR gene-editing technology. This marks Claude's first significant contribution to Anthropic's biology research endeavors. The discovery emerged shortly after Reuters reported that Anthropic had quietly established a wet lab in the San Francisco Bay Area, indicating the company's growing interest in life sciences and drug-related research beyond its computer-based activities.

Claude's analysis of extensive DNA databases led to the identification of an unusual system centered around a reverse transcriptase (RT), an enzyme responsible for copying RNA into DNA. Anthropic has designated this system as array-associated reverse transcriptases, or ART. The system comprises repeating DNA sequences that mirror patterns observed in CRISPR, according to Anthropic.

While the primary RT had been previously identified in research, Claude was notably the first to recognize critical elements of the larger system, such as an array of non-coding DNA sequences and an extra protein with an unknown function.